Back
Structure Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
GPCR
Structure Therapeutics
Last Price:
30.10
Seasonality Move:
-11.15%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight buying pressure.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.14 | Sell |
| 20-day SMA: | 37.33 | Sell |
| 50-day SMA: | 39.14 | Sell |
| 200-day SMA: | 39.9 | Sell |
| 8-day EMA: | 34.63 | Sell |
| 20-day EMA: | 36.62 | Sell |
| 50-day EMA: | 38.09 | Sell |
| 200-day EMA: | 39.32 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.59 | Sell |
| Relative Strength Index (14 RSI): | 34.81 | Sell |
| Chaikin Money Flow: | 88369 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.26 - 40.04) | Sell |
| Bollinger Bands (100): | (35.86 - 41.3) | Sell |
Structure Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 32.71 while GPCR 8-day simple moving average is 35.14, which is a Sell signal.
- The stock price of GPCR is 32.71 while Structure Therapeutics 20-day SMA is 37.33, which makes it a Sell.
- Structure Therapeutics 50-day simple moving average is 39.14 while GPCR share price is 32.71, making it a Sell technically.
- GPCR stock price is 32.71 and Structure Therapeutics 200-day simple moving average is 39.90, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
26
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a Sell
The current Structure Therapeutics [GPCR] share price is $32.71. The Score for GPCR is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.87B
Price in USD:
32.71
Share Volume:
489.26K
Structure Therapeutics 52-Week Range
52-Week High:
66.38
52-Week Low:
26.61
Sell
26
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?
The Structure Therapeutics stock price is 32.71 USD today. -
Will GPCR stock go up or go down?
Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Structure Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 32.71 while GPCR 8-day exponential moving average is 34.63, which is a Sell signal.
- The stock price of GPCR is 32.71 while Structure Therapeutics 20-day EMA is 36.62, which makes it a Sell.
- Structure Therapeutics 50-day exponential moving average is 38.09 while GPCR share price is 32.71, making it a Sell technically.
- GPCR stock price is 32.71 and Structure Therapeutics 200-day simple moving average is 39.32, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
- GPCR Moving Average Covergence Divergence (MACD) indicator is -1.59, suggesting Structure Therapeutics is a Sell
- Structure Therapeutics Relative Strength Index (RSI) is 34.81, which suggest Structure Therapeutics is oversold
- The Bollinger Bands (25) for Structure Therapeutics is (35.26 - 40.04), which suggest Structure Therapeutics is a Sell
- The Bollinger Bands (100) for Structure Therapeutics is (35.86 - 41.3), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.